𝔖 Bobbio Scriptorium
✦   LIBER   ✦

2110 POSTER Active specific immunotherapy with NGcGM3/ VSSP/ Montanide ISA-51 (CIMAVaxG) vaccine in the treatment of patients with metastatic breast cancer: Results of a randomized phase II clinical trial

✍ Scribed by A. Macias; A. Torres; A. Montenegro; P. Marinello; R. Rodriguez; V. Mulens; A. Carr; Z. Mazorra; R. Perez; L.E. Fernandez


Book ID
118625714
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
57 KB
Volume
5
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.